1
Published 2013
World Health Organization
...Guideline on country pharmaceutical pricing policies...

2
Published 2020
World Health Organization
...Guideline on country pharmaceutical pricing policies...

3
by Mestre-Ferrandiz, Jorge
Published 2022
World Health Organization
... focused on price, which are covered elsewhere in the report series). This report explores various types...

4
by Davis, Sarah
Published 2014
National Institute for Health and Care Excellence (NICE)
... not to be cost-effective even if they are zero priced. There may be costs associated with delivering...

5
by Haytmanek, Elizabeth, McClure, Katherine
Published 2010
National Academies Press
...In 2007 and 2008, the world witnessed a dramatic increase in food prices. The global financial...

6
by Davis, Sarah
Published 2014
National Institute for Health and Care Excellence (NICE)
... not to be cost-effective even if they are zero priced. There may be costs associated with delivering...

7
by Webb, Erin, Richardson, Erica, Vogler, Sabine, Panteli, Dimitra
Published 2022
Goverment of Malta, Office of the Deputy Prime Minister, Ministry for Health
... price transparency would have a negative impact on accessibility, because pharmaceutical companies may...

8
by Németh, Bertalan, Csanádi, Marcell, Inotai, András, Ameyaw, David
Published 2022
World Health Organization
... on financing high-priced medicines. The market access strategies for innovative medicines in LICs usually...

9
by Docteur, Elizabeth
Published 2022
World Health Organization
...Concerns about affordable access to medicines reflect the emergence of new, high-priced medicines...

10
by Lemmens, Trudo, Ghimire, Kanksha Mahadevia, Perehudoff, Katrina, Persaud, Navindra
Published 2022
World Health Organization
...High prices can significantly restrict access to medicines and may have an impact on health equity...

11
by Vogler, Sabine, Paris, Valérie, Panteli, Dimitra
Published 2018
World Health Organization, Regional Office for Europe
...1. Policy-makers and purchasers increasingly face very high price tags for new medicines, and some...

12
by Vogler, Sabine, Paris, Valérie, Panteli, Dimitra
Published 2018
World Health Organization, Regional Office for Europe
...1. Policy-makers and purchasers increasingly face very high price tags for new medicines, and some...

15
Published 2010
National Academies Press
Table of Contents: ... -- Allocating medical expenditures : a treatment-of-disease organizing framework -- Measuring prices...

16
by Pray, Leslie A.
Published 2012
National Academies Press
Table of Contents: ...Introduction -- The economics of food prices -- Understanding measures and strategies -- Examining...

17
by Mackie, Christopher D.
Published 2009
National Academies Press
Table of Contents: ... approach -- Price indexes: calculating real medical care GDP -- Summary, perspective, and prospects...

18
by Pankevich, Diana E.
Published 2014
National l Academies Press
Table of Contents: ...: Ineffective Supply Chains -- Challenge: High Pricing and Poor Financing -- Perspectives on Next Steps...

19
Published 2021
Canadian Agency for Drugs and Technologies in Health
... co-administration with rFVIII. A price reduction of 40% is required for rVWF to have a treatment...

20
Published 2020
Canadian Agency for Drugs and Technologies in Health
... was 0% at a threshold of $50,000 per QALY (and even at a threshold of $100,000 per QALY). Price...